Skip to main content
SpringerLink
Log in

Manage nausea and vomiting in terminally ill cancer patients by identifying the cause and selecting appropriate treatment

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Glare PA, Dunwoodie D, Clark K, et al. Treatment of nausea and vomiting in terminally ill cancer patients. Drugs 2008; 68(18): 2575–90

    Article  PubMed  CAS  Google Scholar 

  2. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med 1993; 329(24): 1790–6

    Article  PubMed  CAS  Google Scholar 

  3. Critchley P, Plach N, Grantham M, et al. Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review. J Pain Symptom Manage 2001; 22(2): 631–4

    Article  PubMed  CAS  Google Scholar 

  4. Golding JF, Stott JR. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol 1997; 43(6): 633–7

    Article  PubMed  CAS  Google Scholar 

  5. Baines M, Oliver DJ, Carter RL. Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet 1985; 2(8462): 990–3

    Article  PubMed  CAS  Google Scholar 

  6. Aapro M. 5-HT3-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology 2005; 69(2): 97–109

    Article  PubMed  CAS  Google Scholar 

  7. Mannix KA. Palliation of nausea and vomiting. In: Doyle D, Hanks G, Cherny NI, et al., editors. Oxford textbook of palliative medicine. 3rd ed. Oxford: Oxford University Press, 2004: 459–68

    Google Scholar 

  8. Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer 2002; 12(2): 135–43

    Article  PubMed  Google Scholar 

  9. Ripamonti C, Twycross R, Baines M, et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 2001; 9(4): 223–33

    Article  PubMed  CAS  Google Scholar 

  10. Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med 2008; 358(23): 2482–94

    Article  PubMed  CAS  Google Scholar 

  11. Dando TM, Perry CM. Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs 2004; 64(7): 777–94

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manage nausea and vomiting in terminally ill cancer patients by identifying the cause and selecting appropriate treatment. Drugs Ther. Perspect 25, 14–16 (2009). https://doi.org/10.2165/0042310-200925070-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/0042310-200925070-00004

Search

Navigation